Madhvi Rao Selected Research

RBX 8700

4/2008

Utilization of Bombyx mori larvae as a surrogate animal model for evaluation of the anti-infective potential of oxazolidinones.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Madhvi Rao Research Topics

Disease

4	Infections 01/2021 - 03/2009
3	Body Weight (Weight, Body) 12/2016 - 04/2008
2	Urinary Tract Infections (Urinary Tract Infection) 01/2019 - 01/2018
1	Cystic Fibrosis (Mucoviscidosis) 01/2021
1	Pseudomonas Infections 01/2019
1	Bacterial Meningitis 01/2019
1	Gram-Negative Bacterial Infections 01/2018
1	Abscess 12/2016
1	Foreign Bodies (Foreign Body) 12/2016
1	Bacterial Infections (Bacterial Infection) 11/2011

Drug/Important Bio-Agent (IBA)

3	Pharmaceutical PreparationsIBA 01/2019 - 01/2018
3	Linezolid (Zyvox)FDA Link 12/2016 - 04/2008
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 11/2011
2	DS86760016IBA 01/2019 - 01/2018
1	Virulence Factors (Pathogenicity Factors)IBA 01/2021
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2021
1	3- (aminomethyl)- 7- (3- hydroxypropoxy)- 1- hydroxy- 1,3- dihydro- 2,1- benzoxaboroleIBA 01/2018
1	tedizolidIBA 12/2016
1	Rifampin (Rifampicin)FDA LinkGeneric 12/2016
1	RBx 11760IBA 12/2016
1	Therapeutic UsesIBA 11/2011
1	RBX 8700IBA 04/2008
1	ranbezolidIBA 04/2008
1	Vancomycin FDA LinkGeneric 04/2008

Therapy/Procedure

1	Catheters 01/2019